2025-08-14 |
13G/A
|
UNCY / Unicycive Therapeutics, Inc.
|
|
|
796,558 |
|
|
|
2025-08-14 |
13G/A
|
OTLK / Outlook Therapeutics, Inc.
|
|
2,220,000 |
2,220,000 |
|
|
|
2025-08-14 |
13G/A
|
VTGN / Vistagen Therapeutics, Inc.
|
|
2,055,834 |
2,055,834 |
|
|
|
2025-08-14 |
13G/A
|
PMN / ProMIS Neurosciences, Inc.
|
|
3,334,520 |
3,334,520 |
|
|
|
2025-08-14 |
13G/A
|
CNTX / Context Therapeutics Inc.
|
|
4,683,711 |
4,683,711 |
|
|
|
2025-06-20 |
13G
|
|
|
|
10,576,827 |
|
|
|
2025-05-15 |
13G/A
|
VTGN / Vistagen Therapeutics, Inc.
|
|
2,055,834 |
2,055,834 |
|
|
|
2025-05-15 |
13G/A
|
OTLK / Outlook Therapeutics, Inc.
|
|
2,220,000 |
2,220,000 |
|
|
|
2025-05-15 |
13G/A
|
OPTN / OptiNose, Inc.
|
|
896,585 |
526,315 |
|
|
|
2025-05-15 |
13G/A
|
CNTX / Context Therapeutics Inc.
|
|
4,683,711 |
4,683,711 |
|
|
|
2025-05-14 |
13G
|
ZURA / Zura Bio Limited
|
|
3,170,194 |
3,170,194 |
|
|
|
2025-02-14 |
13G/A
|
PMN / ProMIS Neurosciences, Inc.
|
|
3,007,183 |
3,334,520 |
|
|
|
2025-02-14 |
13G/A
|
UNCY / Unicycive Therapeutics, Inc.
|
|
9,522,432 |
11,473,166 |
|
|
|
2025-02-14 |
13G/A
|
VTGN / Vistagen Therapeutics, Inc.
|
|
2,729,909 |
2,055,834 |
|
|
|
2025-02-14 |
13G/A
|
OPTN / OptiNose, Inc.
|
|
|
896,585 |
|
|
|
2025-02-14 |
13G/A
|
OTLK / Outlook Therapeutics, Inc.
|
|
2,481,973 |
2,220,000 |
|
|
|
2025-02-14 |
13G/A
|
CNTX / Context Therapeutics Inc.
|
|
6,934,982 |
4,683,711 |
|
|
|
2025-02-14 |
13G/A
|
NGNE / Neurogene Inc.
|
|
1,004,291 |
442,761 |
|
|
|
2025-02-14 |
13G/A
|
ZURA / Zura Bio Limited
|
|
3,263,672 |
3,170,194 |
|
|
|
2024-11-14 |
13G/A
|
ZURA / Zura Bio Limited
|
|
3,295,000 |
3,263,672 |
|
|
|
2024-11-14 |
13G/A
|
UNCY / Unicycive Therapeutics, Inc.
|
|
8,559,000 |
9,522,432 |
|
|
|
2024-11-14 |
13G/A
|
VTGN / Vistagen Therapeutics, Inc.
|
|
2,792,927 |
2,729,909 |
|
|
|
2024-11-14 |
13G/A
|
PMN / ProMIS Neurosciences, Inc.
|
|
3,005,698 |
3,007,183 |
|
|
|
2024-11-14 |
13G/A
|
OPTN / OptiNose, Inc.
|
|
11,484,120 |
15,306,939 |
|
|
|
2024-11-14 |
13G/A
|
OTLK / Outlook Therapeutics, Inc.
|
|
2,231,324 |
2,481,973 |
|
|
|
2024-11-14 |
13G/A
|
NGNE / Neurogene Inc.
|
|
994,229 |
1,004,291 |
|
|
|
2024-11-14 |
13G/A
|
CNTX / Context Therapeutics Inc.
|
|
7,419,355 |
6,934,982 |
|
|
|
2024-11-14 |
13G/A
|
ELEV / Elevation Oncology, Inc.
|
|
3,877,172 |
0 |
|
|
|
2024-11-14 |
13G/A
|
URGN / UroGen Pharma Ltd.
|
|
2,620,545 |
758,786 |
|
|
|
2024-11-14 |
13G/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
3,703,433 |
0 |
|
|
|
2024-08-15 |
13G
|
ELEV / Elevation Oncology, Inc.
|
|
|
3,877,172 |
|
|
|
2024-08-05 |
13G
|
PMN / ProMIS Neurosciences, Inc.
|
|
|
3,005,698 |
|
|
|
2024-07-18 |
13G
|
UNCY / Unicycive Therapeutics, Inc.
|
|
|
8,559,000 |
|
|
|
2024-06-05 |
13G
|
CNTX / Context Therapeutics Inc.
|
|
|
7,419,355 |
|
|
|
2024-04-08 |
13G
|
OTLK / Outlook Therapeutics, Inc.
|
|
|
2,231,324 |
|
|
|
2024-02-14 |
13G/A
|
ZURA / Zura Bio Limited
|
|
3,295,000 |
3,295,000 |
|
|
|
2024-02-14 |
13G/A
|
NGNE / Neurogene Inc.
|
|
969,229 |
994,229 |
|
|
|
2024-02-14 |
13G/A
|
OPTN / OptiNose, Inc.
|
|
11,314,719 |
11,484,120 |
|
|
|
2024-02-14 |
13G/A
|
URGN / UroGen Pharma Ltd.
|
|
2,620,545 |
2,620,545 |
|
|
|
2024-02-14 |
13G/A
|
VTGN / Vistagen Therapeutics, Inc.
|
|
2,792,927 |
2,792,927 |
|
|
|
2024-02-14 |
13G/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
3,637,718 |
3,703,433 |
|
|
|
2024-02-14 |
13G/A
|
AVTX / Avalo Therapeutics, Inc.
|
|
|
2,085 |
|
|
|
2024-02-14 |
13G/A
|
DTIL / Precision BioSciences, Inc.
|
|
8,099,799 |
0 |
|
|
|
2024-02-14 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
6,360,161 |
0 |
|
|
|
2023-12-27 |
13G
|
NGNE / Neurogene Inc.
|
|
|
969,229 |
|
|
|
2023-10-12 |
13G
|
VTGN / Vistagen Therapeutics, Inc.
|
|
|
2,792,927 |
|
|
|
2023-09-15 |
13G
|
URGN / UroGen Pharma Ltd.
|
|
|
2,620,545 |
|
|
|
2023-06-16 |
13G
|
ZURA / Zura Bio Limited
|
|
|
3,295,000 |
|
|
|
2023-04-13 |
13G
|
HRTX / Heron Therapeutics, Inc.
|
|
|
6,360,161 |
|
|
|
2023-02-27 |
13G
|
DTIL / Precision BioSciences, Inc.
|
|
3,801,305 |
8,099,799 |
|
|
|
2023-02-14 |
13G/A
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
1,280,000 |
1,055,801 |
|
|
|
2023-02-14 |
13G/A
|
OPTN / OptiNose, Inc.
|
|
11,314,719 |
11,314,719 |
|
|
|
2023-02-14 |
13G/A
|
DTIL / Precision BioSciences, Inc.
|
|
5,755,396 |
3,801,305 |
|
|
|
2023-02-14 |
13G/A
|
ETNB / 89bio, Inc.
|
|
2,100,000 |
700,000 |
|
|
|
2023-02-14 |
13G/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
3,448,521 |
3,637,718 |
|
|
|
2023-02-13 |
13G
|
/ Avalo Therapeutics Inc
|
|
|
974,639 |
|
|
|
2022-12-01 |
13G
|
OPTN / OptiNose, Inc.
|
|
|
11,314,719 |
|
|
|
2022-09-30 |
13G
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
3,448,521 |
|
|
|
2022-07-08 |
13G
|
ETNB / 89bio, Inc.
|
|
|
2,100,000 |
|
|
|
2022-07-01 |
13G
|
DTIL / Precision BioSciences, Inc.
|
|
|
5,755,396 |
|
|
|
2022-05-18 |
13G
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
|
1,280,000 |
|
|
|
2022-02-14 |
13G/A
|
IFRX / InflaRx N.V.
|
|
4,400,000 |
0 |
|
|
|
2021-03-08 |
13G
|
IFRX / InflaRx N.V.
|
|
|
4,400,000 |
|
|
|
2021-02-16 |
13G/A
|
US2103731061 / Constellation Pharmaceuticals Inc
|
|
2,301,457 |
1,024,800 |
|
|
|
2021-02-16 |
13G/A
|
VYNE / VYNE Therapeutics Inc.
|
|
1,652,013 |
0 |
|
|
|
2021-02-16 |
13G/A
|
TGTX / TG Therapeutics, Inc.
|
|
5,434,783 |
0 |
|
|
|
2021-02-16 |
13G/A
|
GERN / Geron Corporation
|
|
23,097,117 |
12,754,228 |
|
|
|
2021-02-16 |
13G/A
|
NXTC / NextCure, Inc.
|
|
1,376,532 |
0 |
|
|
|
2021-02-16 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
2,223,789 |
799,722 |
|
|
|
2021-02-16 |
13G/A
|
PRTA / Prothena Corporation plc
|
|
2,100,941 |
977,647 |
|
|
|
2021-02-16 |
13G/A
|
ABEO / Abeona Therapeutics Inc.
|
|
8,488,882 |
0 |
|
|
|
2021-02-16 |
13G/A
|
TPST / Tempest Therapeutics, Inc.
|
|
1,729,759 |
270,000 |
|
|
|
2020-07-07 |
13G
|
ABEO / Abeona Therapeutics Inc.
|
|
8,480,470 |
8,488,882 |
|
|
|
2020-06-05 |
13G
|
US2103731061 / Constellation Pharmaceuticals Inc
|
|
|
2,301,457 |
|
|
|
2020-06-01 |
13G
|
GERN / Geron Corporation
|
|
|
23,097,117 |
|
|
|
2020-04-22 |
13D/A
|
ABEO / Abeona Therapeutics Inc.
|
|
8,459,960 |
8,480,470 |
|
|
|
2020-02-21 |
13G
|
NXTC / NextCure, Inc.
|
|
|
1,376,532 |
|
|
|
2020-02-14 |
13G/A
|
CYTK / Cytokinetics, Incorporated
|
|
3,173,288 |
160,073 |
|
|
|
2020-02-14 |
13G/A
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
2,398,409 |
0 |
|
|
|
2020-02-14 |
13G/A
|
STRM / Streamline Health Solutions, Inc.
|
|
1,231,695 |
0 |
|
|
|
2020-02-14 |
13G/A
|
SVRA / Savara Inc.
|
|
1,819,195 |
0 |
|
|
|
2020-02-14 |
13G/A
|
LRMR / Larimar Therapeutics, Inc.
|
|
3,598,392 |
0 |
|
|
|
2020-02-14 |
13G/A
|
ZGNX / Zogenix Inc
|
|
2,250,000 |
670,000 |
|
|
|
2020-02-14 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
2,769,527 |
853,777 |
|
|
|
2020-02-14 |
13G/A
|
TPST / Tempest Therapeutics, Inc.
|
|
1,288,093 |
1,729,759 |
|
|
|
2020-02-14 |
13G/A
|
PRTA / Prothena Corporation plc
|
|
2,066,041 |
2,100,941 |
|
|
|
2020-02-14 |
13G/A
|
VYNE / VYNE Therapeutics Inc.
|
|
2,204,407 |
1,652,013 |
|
|
|
2020-02-14 |
13G/A
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
4,047,561 |
0 |
|
|
|
2020-02-14 |
13G/A
|
BOLD / Boundless Bio, Inc.
|
|
2,325,000 |
0 |
|
|
|
2020-02-14 |
13G/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
7,622,256 |
0 |
|
|
|
2020-02-14 |
13G/A
|
YMTX / Yumanity Therapeutics Inc
|
|
3,045,423 |
0 |
|
|
|
2020-02-14 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
2,082,799 |
2,223,789 |
|
|
|
2020-01-02 |
13G
|
TGTX / TG Therapeutics, Inc.
|
|
|
5,434,783 |
|
|
|
2019-12-30 |
13D
|
ABEO / Abeona Therapeutics Inc.
|
|
2,833,656 |
8,459,960 |
|
|
|
2019-09-16 |
13G
|
ABEO / Abeona Therapeutics Inc.
|
|
|
2,833,656 |
|
|
|
2019-09-16 |
13G
|
BOLD / Boundless Bio, Inc.
|
|
|
2,325,000 |
|
|
|
2019-09-16 |
13G
|
ZGNX / Zogenix Inc
|
|
1,121,331 |
2,250,000 |
|
|
|
2019-08-09 |
13G
|
ZYME / Zymeworks Inc.
|
|
|
2,082,799 |
|
|
|
2019-08-05 |
13G
|
PRTA / Prothena Corporation plc
|
|
|
2,066,041 |
|
|
|
2019-05-14 |
13G
|
PBYI / Puma Biotechnology, Inc.
|
|
|
1,970,000 |
|
|
|
2019-05-14 |
13G/A
|
PBYI / Puma Biotechnology, Inc.
|
|
|
1,096,626 |
|
|
|
2019-02-14 |
13G/A
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
4,030,268 |
4,047,561 |
|
|
|
2019-02-14 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
2,197,283 |
2,769,527 |
|
|
|
2019-02-14 |
13G/A
|
VYNE / VYNE Therapeutics Inc.
|
|
1,556,758 |
2,204,407 |
|
|
|
2019-02-14 |
13G/A
|
TPST / Tempest Therapeutics, Inc.
|
|
1,285,068 |
1,288,093 |
|
|
|
2019-02-14 |
13G/A
|
SVRA / Savara Inc.
|
|
2,243,084 |
1,819,195 |
|
|
|
2019-02-14 |
13G/A
|
LRMR / Larimar Therapeutics, Inc.
|
|
3,500,000 |
3,598,392 |
|
|
|
2019-02-14 |
13G/A
|
YMTX / Yumanity Therapeutics Inc
|
|
2,962,962 |
3,045,423 |
|
|
|
2019-02-14 |
13G/A
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
1,821,548 |
2,398,409 |
|
|
|
2019-02-14 |
13G/A
|
LUMO / Lumos Pharma, Inc.
|
|
1,987,099 |
0 |
|
|
|
2019-02-14 |
13G/A
|
CYTK / Cytokinetics, Incorporated
|
|
3,173,288 |
3,173,288 |
|
|
|
2019-02-14 |
13G/A
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
7,888,581 |
0 |
|
|
|
2019-02-14 |
13G/A
|
STRM / Streamline Health Solutions, Inc.
|
|
18,325,483 |
1,231,695 |
|
|
|
2019-02-14 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
1,473,609 |
955,618 |
|
|
|
2019-01-11 |
13G
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
7,478,275 |
7,622,256 |
|
|
|
2019-01-08 |
13D/A
|
CNXR / Connecture, Inc.
|
|
42,396,565 |
0 |
|
|
|
2018-12-17 |
13G
|
TPST / Tempest Therapeutics, Inc.
|
|
|
1,285,068 |
|
|
|
2018-11-15 |
13G
|
CYTK / Cytokinetics, Incorporated
|
|
|
3,173,288 |
|
|
|
2018-11-05 |
13G
|
YMTX / Yumanity Therapeutics Inc
|
|
|
2,962,962 |
|
|
|
2018-10-19 |
13G
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
|
1,821,548 |
|
|
|
2018-10-10 |
13G/A
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
4,781,708 |
4,030,268 |
|
|
|
2018-08-13 |
13G
|
VYNE / VYNE Therapeutics Inc.
|
|
|
1,556,758 |
|
|
|
2018-08-06 |
13G
|
SVRA / Savara Inc.
|
|
|
2,243,084 |
|
|
|
2018-07-31 |
13D/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
7,478,275 |
7,478,275 |
|
|
|
2018-07-09 |
13G
|
LRMR / Larimar Therapeutics, Inc.
|
|
|
3,500,000 |
|
|
|
2018-07-02 |
13G
|
PTGX / Protagonist Therapeutics, Inc.
|
|
|
1,473,609 |
|
|
|
2018-06-20 |
13D/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
7,478,275 |
7,478,275 |
|
|
|
2018-02-16 |
13D
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
7,478,275 |
7,478,275 |
|
|
|
2018-02-15 |
13D
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
7,478,275 |
|
|
|
2018-02-14 |
13G/A
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
0 |
|
|
|
2018-02-14 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
5,262,346 |
3,817,288 |
|
|
|
2018-02-14 |
13G/A
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
2,216,216 |
797,531 |
|
|
|
2018-02-14 |
13G/A
|
TRVN / Trevena, Inc.
|
|
3,000,650 |
0 |
|
|
|
2018-02-14 |
13G/A
|
ZGNX / Zogenix Inc
|
|
24,805,773 |
1,121,331 |
|
|
|
2018-02-14 |
13G/A
|
CNCE / Concert Pharmaceuticals Inc
|
|
2,101,301 |
669,472 |
|
|
|
2018-02-14 |
13G/A
|
451731103 / Ignyta, Inc.
|
|
4,000,000 |
0 |
|
|
|
2018-02-14 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
1,638,461 |
2,197,283 |
|
|
|
2018-02-14 |
13G/A
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
1,500,000 |
0 |
|
|
|
2018-02-14 |
13G/A
|
APYX / Apyx Medical Corporation
|
|
30,842,683 |
0 |
|
|
|
2018-02-14 |
13G/A
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
4,781,708 |
4,781,708 |
|
|
|
2018-02-14 |
13G/A
|
OCRX / Ocera Therapeutics, Inc.
|
|
20,693,361 |
0 |
|
|
|
2018-02-14 |
13D/A
|
CNXR / Connecture, Inc.
|
|
42,396,565 |
4,239,656 |
|
|
|
2018-02-14 |
13G/A
|
LUMO / Lumos Pharma, Inc.
|
|
1,500,000 |
1,987,099 |
|
|
|
2018-02-14 |
13G/A
|
ARNA / Arena Pharmaceuticals Inc
|
|
30,000,000 |
1,177,119 |
|
|
|
2018-02-14 |
13G/A
|
PTCT / PTC Therapeutics, Inc.
|
|
21,600,001 |
1,085,800 |
|
|
|
2018-02-14 |
13G/A
|
867328601 / Sunesis Pharmaceuticals, Inc.
|
|
19,878,713 |
0 |
|
|
|
2018-02-14 |
13G/A
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
9,105,691 |
7,888,581 |
|
|
|
2018-02-14 |
13G/A
|
ARDM / Aradigm Corp.
|
|
791,870 |
0 |
|
|
|
2018-02-14 |
13G/A
|
STRM / Streamline Health Solutions, Inc.
|
|
21,349,403 |
1,832,548 |
|
|
|
2018-01-09 |
13D
|
CNXR / Connecture, Inc.
|
|
42,396,565 |
4,239,656 |
|
|
|
2017-12-08 |
13G
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
5,262,346 |
|
|
|
2017-10-10 |
13G/A
|
ADMS / Adamas Pharmaceuticals Inc
|
|
2,601,351 |
256,340 |
|
|
|
2017-08-21 |
13G
|
KURA / Kura Oncology, Inc.
|
|
|
1,638,461 |
|
|
|
2017-06-16 |
13G
|
PTCT / PTC Therapeutics, Inc.
|
|
|
2,160,000 |
|
|
|
2017-06-05 |
13G
|
LUMO / Lumos Pharma, Inc.
|
|
|
1,500,000 |
|
|
|
2017-05-10 |
13G/A
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
3,000,000 |
4,781,708 |
|
|
|
2017-04-28 |
13G
|
ARNA / Arena Pharmaceuticals Inc
|
|
|
30,000,000 |
|
|
|
2017-03-16 |
13G
|
CNCE / Concert Pharmaceuticals Inc
|
|
|
2,101,301 |
|
|
|
2017-02-17 |
13G
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
2,010,000 |
2,216,216 |
|
|
|
2017-02-14 |
13G/A
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
2,012,622 |
0 |
|
|
|
2017-02-14 |
13G/A
|
TRVN / Trevena, Inc.
|
|
2,931,900 |
3,000,650 |
|
|
|
2017-02-14 |
13G/A
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
2,769,425 |
3,000,000 |
|
|
|
2017-02-14 |
13G/A
|
ALIM / Alimera Sciences, Inc.
|
|
3,245,000 |
2,293,675 |
|
|
|
2017-02-14 |
13G/A
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
2,334,119 |
2,010,000 |
|
|
|
2017-02-14 |
13G/A
|
451731103 / Ignyta, Inc.
|
|
2,169,916 |
4,000,000 |
|
|
|
2017-02-14 |
13G/A
|
VCEL / Vericel Corporation
|
|
2,086,028 |
0 |
|
|
|
2017-02-14 |
13G/A
|
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
|
|
1,940,000 |
0 |
|
|
|
2017-02-14 |
13G/A
|
ARDM / Aradigm Corp.
|
|
1,002,962 |
791,870 |
|
|
|
2017-02-14 |
13G/A
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
30,756,603 |
0 |
|
|
|
2017-02-14 |
13G/A
|
APYX / Apyx Medical Corporation
|
|
3,046,272 |
3,084,268 |
|
|
|
2017-02-14 |
13G/A
|
ZGNX / Zogenix Inc
|
|
15,185,213 |
2,480,577 |
|
|
|
2017-02-14 |
13G/A
|
ADMS / Adamas Pharmaceuticals Inc
|
|
1,437,335 |
2,601,351 |
|
|
|
2017-02-14 |
13G/A
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
1,366,500 |
1,500,000 |
|
|
|
2017-02-14 |
13G/A
|
STRM / Streamline Health Solutions, Inc.
|
|
20,667,643 |
2,134,940 |
|
|
|
2017-02-14 |
13G/A
|
867328601 / Sunesis Pharmaceuticals, Inc.
|
|
85,123,853 |
1,987,871 |
|
|
|
2017-02-14 |
13G/A
|
OCRX / Ocera Therapeutics, Inc.
|
|
20,597,081 |
2,069,336 |
|
|
|
2017-02-10 |
13G
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
9,105,691 |
|
|
|
2017-02-06 |
13D
|
CNXR / Connecture, Inc.
|
|
4,210,960 |
4,239,656 |
|
|
|
2017-01-03 |
13G
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
1,366,500 |
|
|
|
2016-12-12 |
13G
|
TRVN / Trevena, Inc.
|
|
|
2,931,900 |
|
|
|
2016-11-23 |
13D/A
|
APYX / Apyx Medical Corporation
|
|
27,192,661 |
3,046,272 |
|
|
|
2016-10-11 |
13G
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
|
2,769,425 |
|
|
|
2016-08-22 |
13G
|
ALIM / Alimera Sciences, Inc.
|
|
0 |
3,245,000 |
|
|
|
2016-05-23 |
13G
|
451731103 / Ignyta, Inc.
|
|
2,050,000 |
2,169,916 |
|
|
|
2016-05-09 |
13G
|
451731103 / Ignyta, Inc.
|
|
|
2,050,000 |
|
|
|
2016-02-26 |
13D
|
APYX / Apyx Medical Corporation
|
|
27,192,663 |
2,719,266 |
|
|
|
2016-02-16 |
13G/A
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
1,124,186 |
2,012,622 |
|
|
|
2016-02-16 |
13G
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
3,075,660 |
|
|
|
2016-02-16 |
13G/A
|
APYX / Apyx Medical Corporation
|
|
|
2,719,266 |
|
|
|
2016-02-16 |
13G/A
|
VCEL / Vericel Corporation
|
|
|
2,086,028 |
|
|
|
2016-02-16 |
13G/A
|
SYN / Synthetic Biologics Inc
|
|
|
3,589,400 |
|
|
|
2016-02-16 |
13G/A
|
PTN / Palatin Technologies, Inc.
|
|
|
2,337,000 |
|
|
|
2016-02-16 |
13G/A
|
DSCO / Discovery Laboratories, Inc.
|
|
64,962,513 |
280,952 |
|
|
|
2016-02-16 |
13G/A
|
ACHV / Achieve Life Sciences, Inc.
|
|
|
0 |
|
|
|
2016-02-16 |
13G/A
|
CBMX / CombiMatrix Corp.
|
|
|
0 |
|
|
|
2016-02-16 |
13G/A
|
ZGNX / Zogenix Inc
|
|
14,663,573 |
1,518,521 |
|
|
|
2016-02-16 |
13G/A
|
SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
|
|
|
1,546,888 |
|
|
|
2016-02-16 |
13G/A
|
ADMS / Adamas Pharmaceuticals Inc
|
|
1,080,000 |
1,437,335 |
|
|
|
2016-02-16 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
54,308,554 |
0 |
|
|
|
2016-02-16 |
13G/A
|
OCRX / Ocera Therapeutics, Inc.
|
|
|
2,059,708 |
|
|
|
2016-02-16 |
13G/A
|
ALIM / Alimera Sciences, Inc.
|
|
|
0 |
|
|
|
2016-02-16 |
13G/A
|
CNXR / Connecture, Inc.
|
|
4,127,232 |
4,210,960 |
|
|
|
2016-02-16 |
13G/A
|
VIRX / Viracta Therapeutics, Inc.
|
|
85,123,503 |
8,512,385 |
|
|
|
2016-02-16 |
13G/A
|
SSKN / STRATA Skin Sciences, Inc.
|
|
|
0 |
|
|
|
2016-02-16 |
13G/A
|
ARDM / Aradigm Corp.
|
|
|
1,002,962 |
|
|
|
2016-02-16 |
13G/A
|
STRM / Streamline Health Solutions, Inc.
|
|
|
2,066,764 |
|
|
|
2016-01-15 |
13G
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
|
2,334,119 |
|
|
|
2015-12-28 |
13G
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
8,512,350 |
|
|
|
2015-12-24 |
13G
|
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
|
|
1,824,300 |
1,940,000 |
|
|
|
2015-11-06 |
13G
|
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
|
|
|
1,824,300 |
|
|
|
2015-10-05 |
13G
|
ZGNX / Zogenix Inc
|
|
|
1,466,357 |
|
|
|
2015-08-24 |
13G
|
ADMS / Adamas Pharmaceuticals Inc
|
|
|
1,080,000 |
|
|
|
2015-07-28 |
13G
|
WINT / Windtree Therapeutics, Inc.
|
|
|
6,496,251 |
|
|
|
2015-04-28 |
13G
|
ALBO / Albireo Pharma Inc
|
|
|
5,430,855 |
|
|
|
2015-04-16 |
13G
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
|
1,124,186 |
|
|
|
2015-02-17 |
13G/A
|
SYN / Synthetic Biologics Inc
|
|
|
7,588,341 |
|
|
|
2015-02-17 |
13G/A
|
ARDM / Aradigm Corp.
|
|
|
1,002,962 |
|
|
|
2015-02-17 |
13G/A
|
SPHS / Sophiris Bio Inc
|
|
|
0 |
|
|
|
2015-02-17 |
13G/A
|
MELA / MELA Sciences, Inc
|
|
|
670,058 |
|
|
|
2015-02-17 |
13G/A
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
|
250,000 |
|
|
|
2015-02-17 |
13G/A
|
TENX / Tenax Therapeutics, Inc.
|
|
|
0 |
|
|
|
2015-02-17 |
13G/A
|
WGBS / WaferGen Bio-Systems, Inc.
|
|
|
132,456 |
|
|
|
2015-02-17 |
13G
|
CNXR / Connecture, Inc.
|
|
|
5,502,965 |
|
|
|
2015-02-17 |
13G/A
|
ACHV / Achieve Life Sciences, Inc.
|
|
|
1,726,064 |
|
|
|
2015-02-17 |
13G/A
|
STRM / Streamline Health Solutions, Inc.
|
|
|
2,031,889 |
|
|
|
2015-02-17 |
13G/A
|
OCRX / Ocera Therapeutics, Inc.
|
|
|
1,973,136 |
|
|
|
2015-02-17 |
13G/A
|
NUWE / Nuwellis, Inc.
|
|
|
0 |
|
|
|
2015-02-17 |
13G/A
|
APYX / Apyx Medical Corporation
|
|
|
1,991,588 |
|
|
|
2015-02-17 |
13G/A
|
REPH / Societal CDMO Inc
|
|
|
0 |
|
|
|
2015-02-17 |
13G/A
|
CBMX / CombiMatrix Corp.
|
|
|
970,874 |
|
|
|
2015-02-17 |
13G/A
|
ALIM / Alimera Sciences, Inc.
|
|
|
2,619,853 |
|
|
|
2015-02-17 |
13G/A
|
SAVA / Cassava Sciences, Inc.
|
|
|
0 |
|
|
|
2015-02-17 |
13G/A
|
AVEO / AVEO Pharmaceuticals Inc
|
|
|
0 |
|
|
|
2015-01-20 |
13G
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
|
1,132,000 |
|
|
|
2014-11-10 |
13G
|
SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
|
|
|
6,430,868 |
|
|
|
2014-10-24 |
13G
|
MELA / MELA Sciences, Inc
|
|
|
601,299 |
|
|
|
2014-10-20 |
13G
|
SYN / Synthetic Biologics Inc
|
|
|
7,321,380 |
|
|
|
2014-09-25 |
13G
|
ALIM / Alimera Sciences, Inc.
|
|
|
2,468,662 |
|
|
|
2014-09-22 |
13G
|
VCEL / Vericel Corporation
|
|
|
2,170,000 |
|
|
|
2014-07-21 |
13G
|
OCRX / Ocera Therapeutics, Inc.
|
|
|
1,964,874 |
|
|
|
2014-07-07 |
13G
|
02318X100 / Ambit Biosciences Corp
|
|
|
1,053,895 |
|
|
|
2014-07-07 |
13G
|
ACHV / Achieve Life Sciences, Inc.
|
|
|
2,111,590 |
|
|
|
2014-03-28 |
13G
|
TENX / Tenax Therapeutics, Inc.
|
|
|
2,000,000 |
|
|
|
2014-03-18 |
13G
|
REPH / Societal CDMO Inc
|
|
|
580,000 |
|
|
|
2014-02-18 |
13G
|
ANTH / Anthera Pharmaceuticals, Inc.
|
|
|
1,000,000 |
|
|
|
2014-02-14 |
13G/A
|
SAVA / Cassava Sciences, Inc.
|
|
|
2,797,689 |
|
|
|
2014-02-14 |
13G/A
|
SVRA / Savara Inc.
|
|
|
4,194,934 |
|
|
|
2014-02-14 |
13G/A
|
STRM / Streamline Health Solutions, Inc.
|
|
|
1,929,273 |
|
|
|
2014-02-14 |
13G/A
|
02318X100 / Ambit Biosciences Corp
|
|
|
732,600 |
|
|
|
2014-02-14 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
|
1,048,024 |
|
|
|
2014-02-14 |
13G/A
|
AVEO / AVEO Pharmaceuticals Inc
|
|
|
3,000,000 |
|
|
|
2014-02-14 |
13G/A
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
|
0 |
|
|
|
2014-02-14 |
13G/A
|
WGBS / WaferGen Bio-Systems, Inc.
|
|
|
994,741 |
|
|
|
2014-02-14 |
13G
|
CBMX / CombiMatrix Corp.
|
|
|
1,095,541 |
|
|
|
2014-02-14 |
13G/A
|
FURX / Furiex Pharmaceuticals, Inc.
|
|
|
319,536 |
|
|
|
2014-02-14 |
13G/A
|
NUWE / Nuwellis, Inc.
|
|
|
915,917 |
|
|
|
2014-02-14 |
13G/A
|
SPHS / Sophiris Bio Inc
|
|
|
1,379,660 |
|
|
|
2014-02-14 |
13G/A
|
PTN / Palatin Technologies, Inc.
|
|
|
2,337,000 |
|
|
|
2014-02-14 |
13G/A
|
ACHV / Achieve Life Sciences, Inc.
|
|
|
217,301 |
|
|
|
2014-02-06 |
13G
|
ARDM / Aradigm Corp.
|
|
|
40,322,580 |
|
|
|
2013-12-30 |
13G
|
AVEO / AVEO Pharmaceuticals Inc
|
|
|
2,950,100 |
|
|
|
2013-12-23 |
13G
|
APYX / Apyx Medical Corporation
|
|
|
1,947,747 |
|
|
|
2013-08-26 |
13G
|
SPHS / Sophiris Bio Inc
|
|
|
1,280,000 |
|
|
|
2013-07-08 |
13G
|
SAVA / Cassava Sciences, Inc.
|
|
|
2,386,700 |
|
|
|
2013-06-24 |
13G
|
SVRA / Savara Inc.
|
|
|
8,700,000 |
|
|
|
2013-05-28 |
13G
|
02318X100 / Ambit Biosciences Corp
|
|
|
1,000,000 |
|
|
|
2013-05-28 |
13G
|
STML / Stemline Therapeutics, Inc.
|
|
|
620,627 |
|
|
|
2013-04-22 |
13G
|
NUWE / Nuwellis, Inc.
|
|
|
950,000 |
|
|
|
2013-02-14 |
13G/A
|
OREX / Orexigen Therapeutics, Inc.
|
|
|
0 |
|
|
|
2013-02-14 |
13G/A
|
STRM / Streamline Health Solutions, Inc.
|
|
|
1,402,102 |
|
|
|
2013-02-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
482,001 |
|
|
|
2013-02-14 |
13G/A
|
TNGNQ / Tengion, Inc.
|
|
|
0 |
|
|
|
2013-02-14 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
|
1,374,228 |
|
|
|
2013-02-14 |
13G/A
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
|
2,300,021 |
|
|
|
2013-02-14 |
13G/A
|
WGBS / WaferGen Bio-Systems, Inc.
|
|
|
4,622,922 |
|
|
|
2013-02-14 |
13G/A
|
ZGNX / Zogenix Inc
|
|
|
3,697,900 |
|
|
|
2013-02-14 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
|
0 |
|
|
|
2013-02-14 |
13G/A
|
FURX / Furiex Pharmaceuticals, Inc.
|
|
|
631,737 |
|
|
|
2013-02-14 |
13G/A
|
PTN / Palatin Technologies, Inc.
|
|
|
2,637,207 |
|
|
|
2013-02-14 |
13G/A
|
WINT / Windtree Therapeutics, Inc.
|
|
|
871,454 |
|
|
|
2013-02-14 |
13G/A
|
ACHV / Achieve Life Sciences, Inc.
|
|
|
1,039,793 |
|
|
|
2012-12-10 |
13G
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
|
1,930,000 |
|
|
|
2012-12-10 |
13G
|
FURX / Furiex Pharmaceuticals, Inc.
|
|
|
525,000 |
|
|
|
2012-08-27 |
13G
|
STRM / Streamline Health Solutions, Inc.
|
|
|
1,385,611 |
|
|
|
2012-08-03 |
13G
|
ZGNX / Zogenix Inc
|
|
|
5,750,000 |
|
|
|
2012-02-14 |
13G/A
|
IMNP / Immune Pharmaceuticals Inc.
|
|
|
3,181,818 |
|
|
|
2012-02-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
2,618,418 |
|
|
|
2012-02-14 |
13G/A
|
SLTM / Solta Medical Inc
|
|
|
1,485,149 |
|
|
|
2012-02-14 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
|
4,750,000 |
|
|
|
2012-02-14 |
13G/A
|
ANIP / ANI Pharmaceuticals, Inc.
|
|
|
882,353 |
|
|
|
2012-02-14 |
13G/A
|
BDSI / Biodelivery Sciences International
|
|
|
0 |
|
|
|
2012-02-14 |
13G
|
OREX / Orexigen Therapeutics, Inc.
|
|
|
5,895,301 |
|
|
|
2012-02-14 |
13G/A
|
TNGNQ / Tengion, Inc.
|
|
|
1,901,603 |
|
|
|
2012-02-14 |
13G
|
ASMB / Assembly Biosciences, Inc.
|
|
|
750,000 |
|
|
|
2012-02-14 |
13G/A
|
WINT / Windtree Therapeutics, Inc.
|
|
|
2,200,000 |
|
|
|
2012-02-14 |
13G/A
|
ACHV / Achieve Life Sciences, Inc.
|
|
|
894,114 |
|
|
|